Search

You searched for "myopic"

410 results found

Urban Changes and Rural Struggles for Ophthalmology in China

1 December 2013 |
China is by far the most populated country in the world, with over 1.3 billion inhabitants. It is also the country with the highest number of blind and visually impaired people. As a developing country, half of China’s population lives...

The most frequent complaints and claims in ophthalmology – a Medical Protection Society (MPS) analysis

4 December 2018 | | Optometry, Cataract and Refractive, Glaucoma
The authors look at the reasons behind medico-legal cases reported to MPS and share key learning points. Complications following ophthalmology surgery are rare, however, medico-legal cases are not uncommon due to the significant impact they can have on patients’ lifestyles....

Measuring patient-reported outcomes after refractive surgery to assess patient satisfaction

1 June 2019 | | Cataract and Refractive, Ophthalmology
Patient-reported outcomes enable surgeons to evaluate patients’ symptoms and satisfaction after laser vision correction. The great majority of patients are pleased with their outcomes from laser vision correction, whether it is with photorefractive keratectomy, laser in-situ keratomileusis (LASIK), or small...

Troubleshooting in LASIK

1 April 2017 | | Cataract and Refractive
Contemporary laser in situ keratomileusis (LASIK) is safe and effective. It remains the dominant intervention in routine refractive surgery for a good reason: predictable results, rapid visual recovery, and relatively simple strategies for revision treatment. Over 95% of patients are...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | Retina / Uvea / Vitreous
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

Part 2: the Arclight Device: frugal imaging for eyecare

3 June 2024 | | Ophthalmology
In this three-part series (Click here for Part 1) Andrew Blaikie and his team explore the role and application of the Arclight Device in Imaging of the Eye. There are many different types of ophthalmic imaging tools; from simply taking...

Aqueous misdirection: a case series of unexpected surgical complications

3 June 2024 | | Glaucoma
Aqueous misdirection (AM), also known as malignant glaucoma, is a form of secondary glaucoma that typically presents with shallowing of the anterior chamber (AC), raised intraocular pressure (IOP), and reduced visual acuity (VA) in the presence of patent peripheral iridotomies...

IN FOCUS - Beyond 2020: what next for global eye health?

1 April 2020 | | Ophthalmology
The year 2020 is a pivotal year for global eye health. It marks the conclusion of ‘VISION 2020: The Right to Sight’ which has guided action for the past two decades, and the end of the World Health Organization (WHO)...

The Worshipful Company Of Spectacle Makers closes 2023 with 9 new liverymen and 1 new court assistant

12 January 2024 | awards, organisation, healthcare professional, allied professions, livery, collaboration
The Worshipful Company of Spectacle Makers brought a successful 2023 to a close with the admission of 9 new Liverymen at its December Court Lunch.

Specsavers Launches brand new Roblox Obby

11 April 2024 | optometry, opticians, gamines, entertainment, Education, children, industry
Specsavers has unveiled the ‘Specsavers Obby’, a new branded obstacle course game and virtual merchandise giveaway on Roblox, marking the high-street retailer’s commitment to educating younger generations and continued steps into the gaming space.

Innovative 3D printing could revolutionise treatment for cataracts and other eye conditions

28 May 2024 | research, breakthrough, cataract, refractive, IOL, intraocular, lens, 3D, printing
University of East Anglia researchers have made a significant breakthrough in ocular device technology with the introduction of a novel resin for 3D printing intraocular devices. This innovation has potential to enhance the manufacture of eye implants universally used in cataract and refractive surgeries.

Moorfields Eye Charity’s six-year growth and impact

12 July 2024 | industry, infrastructure, Moorfields, eyecare, eclo, report
Moorfields Eye Charity launches its impact report showing that it has grown to become the leading charity in the UK funding research into eye health and innovation and improvement in patient care.